CPT2 and fatty liver disease: Acyl-CoA produced by Acyl-CoA synthase long chain (ACSL1), which is not used for acyl-carnitine shuttling via CPT1, CACT and CPT2, could also be re-esterified to triacylglycerol and deposited in the liver cells causing hepatic steatosis.